好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Epidemiology of Autoimmune Encephalitis and Comparison to Infectious Causes – Experience from a Tertiary Center
Autoimmune Neurology
P3 - Poster Session 3 (12:00 PM-1:00 PM)
017

 To compare the epidemiology of autoimmune and infectious encephalitis cases in a large tertiary center during the recent decade.

The incidence of autoimmune encephalitis (AIE) has risen in the last decade, yet recent studies evaluating the current epidemiology of AIE and comparing it to the epidemiology of infectious encephalitis are lacking.

All encephalitis cases, aged 18 and above, admitted to our medical facility between the years 2010-2020 were thoroughly reviewed for demographic, clinical, laboratory, and imaging data and categorized based on etiology.

225 patients with encephalitis were identified. The most common identifiable cause was viral (42%), followed by autoimmune encephalitis (35%), bacterial (18%), and fungal/parasitic (5%). The incidence of AIE cases out of the yearly admitted cases increased substantially, from 3.8/100K in 2010 to 18.8/100K in 2020. The incidence of viral cases also increased while those of bacterial and fungal/parasitic infections remained stable. Patients with AIE were younger compared to infectious patients (p-value<0.001) and had significantly lower markers of systemic and cerebrospinal fluid inflammation (p-value for all <0.001). Seizures were more common among AIE patients (p-value<0.001), yet one-year mortality rates were significantly higher among infectious patients (p-value<0.001).

AIE incidence has risen significantly in our institution during the past decade, with current rates comparable to those of all infectious causes combined. Based on this cohort, clinical clues for an autoimmune etiology include a non-inflammatory cerebrospinal fluid profile, the presence of seizures, and temporal lobe imaging abnormalities (also common in herpetic encephalitis). In light of its rising incidence and the importance of early treatment, AIE should be considered in the differential diagnosis of all encephalitis cases.

Authors/Disclosures
Yahel Segal, MD (Mayo Clinic)
PRESENTER
Dr. Segal has nothing to disclose.
Ofer Rotschild Ofer Rotschild has nothing to disclose.
Yair Mina, MD (NIH) Dr. Mina has nothing to disclose.
Gadi A. Maayan Eshed, MD (Tel Aviv Sourasky Medical Center) Dr. Maayan Eshed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bionaut Labs Ltd.
Tal Levinson (Tel-Aviv Sourasky Medical Center) No disclosure on file
Yael Paran (Ichilov) Yael Paran has nothing to disclose.
Michal Dekel No disclosure on file
Ronit Cohen-Poradosu No disclosure on file
Adi Ashkenazi No disclosure on file
Itamar Moreno No disclosure on file
Orna Aizenstein Lehavi No disclosure on file
Ora Halutz (Tel Aviv Sourasky Medical Center) No disclosure on file
Yifat Alcalay (Tel Aviv Medical Center) Yifat Alcalay has nothing to disclose.
Avi Gadoth, MD (Tel-Aviv Medical Center) Dr. Gadoth has received intellectual property interests from a discovery or technology relating to health care.